Thomas Giese (T Giese)

Publication Activity (10 Years)

Years Active: 2020-2021
Publications (10 Years): 5

Top Topics

Inflammatory Response

Dendritic Cells

Respiratory Syndrome Coronavirus

Top Venues

Therapeutics and clinical risk management

This page only lists publications with an associated author ORCID identifier.

Publications

Claudia Sommerer, Anita Schmitt, Angela Hückelhoven-Krauss, Thomas Giese, Thomas Bruckner, Lei Wang, Paul Schnitzler, Stefan Meuer, Martin Zeier, Michael Schmitt
Peptide Vaccination against Cytomegalovirus Induces Specific T Cell Response in Responses in CMV Seronegative End-Stage Renal Disease Patients. Vaccines 9 (2) (2021)
Jessica Seeßle, Theresa Hippchen, Paul Schnitzler, Julia Gsenger, Thomas Giese, Uta Merle
High rate of HSV-1 reactivation in invasively ventilated COVID-19 patients: Immunological findings. PloS one 16 (7) (2021)
Matthias Munoz Neulinger, Dominik Schaack, Svetlana P Grekova, Andrea S Bauer, Thomas Giese, Gabriel A Salg, Elisa Espinet, Barbara Leuchs, Anette Heller, Jürg P F Nüesch, Miriam Schenk, Michael Volkmar, Nathalia A Giese
Human Retrotransposons and the Global Shutdown of Homeostatic Innate Immunity by Oncolytic Parvovirus H-1PV in Pancreatic Cancer. Viruses 13 (6) (2021)
Ulrike Dapunt, Birgit Prior, Jan Philippe Kretzer, Thomas Giese, Yina Zhao
Bacterial Biofilm Components Induce an Enhanced Inflammatory Response Against Metal Wear Particles. Therapeutics and clinical risk management 16 (2020)
A Oras, B Quirant-Sanchez, D Popadic, S Thunberg, O Winqvist, S Heck, M Cwikowski, D Riemann, B Seliger, E Martinez Caceres, Raivo Uibo, Thomas Giese
Comprehensive flow cytometric reference intervals of leukocyte subsets from six study centers across Europe. Clinical and experimental immunology 202 (3) (2020)